Literature DB >> 12114490

Management of women with a family history of breast cancer in the North West Region of England: training for implementing a vision of the future.

M McAllister, K O'Malley, P Hopwood, B Kerr, A Howell, D G R Evans.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12114490      PMCID: PMC1735171          DOI: 10.1136/jmg.39.7.531

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  6 in total

1.  Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.

Authors:  C Phelps; F Wood; P Bennett; K Brain; J Gray
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

Review 2.  Delivering cancer genetics services--new ways of working.

Authors:  Ros Eeles; Glyn Purland; Jane Maher; D Gareth Evans
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

3.  Mentoring nurses in familial cancer risk assessment and counseling: lessons learned from a formative evaluation.

Authors:  Agnes Masny; Mary E Ropka; Candace Peterson; Dominique Fetzer; Mary B Daly
Journal:  J Genet Couns       Date:  2008-01-26       Impact factor: 2.537

4.  The Teesside cancer family history service: change management and innovation at cancer network level.

Authors:  Paul Brennan; Oonagh Claber; Tracey Shaw
Journal:  Fam Cancer       Date:  2007-05-17       Impact factor: 2.375

5.  The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetic services give patients what they want?

Authors:  Rachel Iredale; Kate Brain; Jonathon Gray; Elizabeth France
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

6.  A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer.

Authors:  Rachel Starkings; Valerie Shilling; Valerie Jenkins; Lesley Fallowfield
Journal:  Breast Cancer Res Treat       Date:  2020-06-23       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.